NBP - NovaBridge Biosciences News

Sectors

NBP

NovaBridge Biosciences

1.75

9 x 1.75

39 x 1.76

bid

ask

0.08

4.10%

01:26 PM

timesize

Ytd	-55.90%
1y	-61.43%

1.74

day range

1.82

1.46

52 week range

6.79

Open	1.82	Prev Close	1.83	Low	1.74	High	1.82	Mkt Cap	210.94M
Vol	157.24K	Avg Vol	823.18K	EPS	-0.39	P/E	-4.69	Forward P/E	N/A
Beta	1.45	Short Ratio	N/A	Inst. Own	N/A	Dividend	N/A	Div Yield	N/A
Ex Div Date	N/A	Earning	07-14	50-d Avg	1.78	200-d Avg	3.18	1yr Est	0.00

NBP News

benzinga.com

NovaBridge Names Srishti Gupta CEO As Sean Fu Steps Down

NovaBridge Biosciences (NASDAQ:NBP) ("NovaBridge" or the "Company"), a clinical-stag

globenewswire.com

NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer

ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge”

globenewswire.com

NovaBridge Biosciences Receives FDA Fast Track Designation for Givastomig in First-Line HER2-Negativ

Registrational Phase 3 Trial Expected to Begin as Early as Q4 2026 Detailed Phase 1b Data Expected t

globenewswire.com

NovaBridge to Present at the 2026 Jefferies Global Healthcare Conference

ROCKVILLE, Md., May 28, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge or

globenewswire.com

NovaBridge to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference

ROCKVILLE, Md., May 12, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge or

benzinga.com

Alpha Buying: Insider Conviction in High-Risk Biotech

benzinga.com

12 Health Care Stocks Moving In Tuesday's After-Market Session

globenewswire.com

NovaBridge Appoints Mark Hagler as President and Chief Commercial Officer to Advance Commercial Stra

Seasoned Biopharma leader bringing deep commercial experience to shape and inform corporate strategy

seekingalpha.com

NovaBridge's Givastomig Could Drive A Major Re-Rating

NovaBridge Biosciences remains a high-risk, catalyst-driven biotech, trading near cash value with a

globenewswire.com

NovaBridge Reports Full Year 2025 Financial Results and Provides Business Update

ROCKVILLE, Md., April 07, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge

globenewswire.com

NovaBridge Announces Productive FDA Type B Meeting on Potential Accelerated Approval Pathway for Giv

FDA confirmed givastomig's potential eligibility for an accelerated approval pathway NovaBridge expe

seekingalpha.com

NovaBridge Biosciences (NBP) Discusses Phase 2a Clinical Data and Development Plan for VIS-101 in We

benzinga.com

Mid-Cap NovaBridge Biosciences Stock Jumps Fueled By Positive Study Data In Eye Disease

NovaBridge Biosciences (NASDAQ: NBP) shares are up on Monday following the announcement of positive

globenewswire.com

NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study

ROCKVILLE, Md., March 09, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge

benzinga.com

Ooma, John Wiley & Sons, Okta And Other Big Stocks Moving Higher On Thursday

Ooma (NYSE:OOMA) shares rose 11.3% after beating Q4 earnings and revenue expectations. Other gainers

globenewswire.com

NovaBridge to Host Business Update Call to Review Phase 2a Data for VIS-101 in Wet AMD on Monday, Ma

VIS-101, purpose-designed to be a best-in-class dual VEGF-A/ANG-2 inhibitor, has the potential to pr

globenewswire.com

NovaBridge to Present at the Leerink Partners 2026 Global Healthcare Conference

ROCKVILLE, Md., March 02, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge

globenewswire.com

NovaBridge Appoints Biotech Leader, Emmett T. Cunningham, Jr, MD, PhD, MPH, as Vice Chairman of the

ROCKVILLE, Md., Feb. 19, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge o

benzinga.com

12 Health Care Stocks Moving In Tuesday's After-Market Session

globenewswire.com

NovaBridge Doses First Patient in Global, Randomized Phase 2 Study of Givastomig Combined with Immun

ROCKVILLE, Md., Feb. 17, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge o

benzinga.com

Amazon To $300? Here Are 10 Top Analyst Forecasts For Friday

globenewswire.com

NovaBridge Announces Open Market Purchases by Executive Chairman, Fu Wei

ROCKVILLE, Md., Jan. 20, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge o

feeds.benzinga.com

What's Going On With NovaBridge Stock Tuesday?

NovaBridge stock was trading higher Tuesday but has since reversed and begun trading lower. NovaBrid

globenewswire.com

NovaBridge Presents Positive Givastomig Dose Expansion Data from the Phase 1b Combination Study in P

ROCKVILLE, Md., Jan. 06, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge o

globenewswire.com

NovaBridge to Ring the Nasdaq Opening Bell on Friday, January 2, 2026

NovaBridge Also Included in the Highly Regarded Nasdaq Biotech Index, Emphasizing its Position as an

globenewswire.com

NovaBridge Presents Positive Ragistomig Phase 1 Dose Expansion Data at ESMO-IO

ROCKVILLE, Md., Dec. 10, 2025 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge o